MCI
LLY icon

MRP Capital Investments’s Eli Lilly LLY Stock Holding History

MRP Capital Investments’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.74M Buy
2,977
+70
+2% +$71K 2.39% 10
2025
Q4 		$3.12M Buy
2,907
+770
+36% +$736K 2.62% 7
2025
Q3 		$1.67M Sell
2,137
-960
-31% -$714K 1.43% 24
2025
Q2 		$2.41M Buy
3,097
+130
+4% +$101K 1.66% 14
2025
Q1 		$2.45M Sell
2,967
-10
-0.3% -$8.32K 2.29% 10
2024
Q4 		$2.3M Buy
2,977
+200
+7% +$166K 2.09% 13
2024
Q3 		$2.46M Sell
2,777
-178
-6% -$160K 2.34% 7
2024
Q2 		$2.68M Sell
2,955
-175
-6% -$140K 2.5% 7
2024
Q1 		$2.44M Sell
3,130
-210
-6% -$149K 2.44% 8
2023
Q4 		$1.95M Sell
3,340
-3,241
-49% -$1.89M 2.09% 9
2023
Q3 		$3.65M Buy
6,581
+3,003
+84% +$1.55M 4.04% 2
2023
Q2 		$1.68M Buy
+3,578
New +$1.5M 1.64% 10
2023
Q1 		– Sell
-3,482
Closed -$1.27M – 250
2022
Q4 		$1.27M Buy
+3,482
New +$1.23M 1.41% 25

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

MRP Capital Investments's LLY Position: Q1 2026 in Review

MRP Capital Investments increased its Eli Lilly (LLY) stake by 2.4% in Q1 2026, buying an estimated $71K and bringing the position to 2,977 shares worth $2.74M. The position accounts for 2.39% of the portfolio, ranked #10.

MRP Capital Investments first reported a position in LLY in Q4 2022 and has held it in 13 quarters since. The position peaked at $3.65M in Q3 2023. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • MRP Capital Investments held 2,977 shares of Eli Lilly worth $2.74M as of Q1 2026.
  • MRP Capital Investments bought 70 Eli Lilly shares in Q1 2026, an estimated $71K.
  • Eli Lilly made up 2.39% of MRP Capital Investments's portfolio in Q1 2026, its #10 holding.
  • MRP Capital Investments first reported a position in Eli Lilly in Q4 2022 and has held it in 13 quarters since.
  • MRP Capital Investments's Eli Lilly position peaked at $3.65M in Q3 2023.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on MRP Capital Investments's 13F filing for Q1 2026, filed 14 May 2026.